Dr. Richard Agnew, MD

General Surgery  ·  
Male  ·  
Age 70
(5)
Insurances Accepted  ·  Save
Dr. Richard Agnew, MD
Dr. Richard Agnew, MD is a general surgery specialist in Jacksonville, FL and has been practicing for 43 years. He graduated from Vanderbilt University School Of Medicine in 1975 and specializes in general surgery.

Risks associated with the TAVR procedure include death, stroke and major bleeding

Important Risk Information for Patients

Indications:

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be at intermediate or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 3% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for patients with symptomatic heart disease due to failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic or mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 8% at 30 days, based on the STS risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

Contraindications (Who should not use):

The Edwards SAPIEN 3 transcatheter heart valve and delivery system should not be used in patients who:

  • Cannot tolerate medications that thin the blood or prevent blood clots from forming.
  • Have an active infection in the heart or elsewhere.

Warnings:

  • There may be an increased risk of stroke in transcatheter aortic valve replacement procedures, compared to other standard treatments for aortic stenosis in the high or greater risk population.
  • If an incorrect valve size for your anatomy is used, it may lead to heart injury, valve leakage, movement, or dislodgement.
  • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are allergic to chromium, nickel, molybdenum, manganese, copper, silicon, and/or polymeric materials.
  • The SAPIEN 3 valve may not last as long in patients whose bodies do not process calcium normally.
  • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
  • Transcatheter aortic heart valve patients should take medications that thin the blood or prevent blood clots from forming, except when likely to have an adverse reaction, as determined by their physician. The Edwards SAPIEN 3 transcatheter heart valve has not been tested for use without medications that thin the blood or prevent blood clots from forming.

Precautions:

The long-term durability of the Edwards SAPIEN 3 transcatheter heart valve is not known at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing. Safety, performance, and durability of the SAPIEN 3 valve has not been established for placement inside a previously implanted transcatheter valve.

The safety and effectiveness of the transcatheter heart valve is also not known for patients who have:

  • An aortic heart valve that is not calcified, contains only one or two leaflets, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks.
  • Previous prosthetic ring in any position.
  • Previous atrial septal occlude.
  • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors.
  • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly.
  • Diseased, abnormal or irregularly shaped vessels leading to the heart. Vessels which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry.
  • Allergies to blood-thinning medications or dye injected during the procedure.
  • For a valve in valve procedure, there is a risk of leakage if the previously implanted tissue valve is not securely in place or if it is damaged. There is also the possibility that a partially detached valve leaflet from the previously implanted valve could block a blood vessel.
  • Additional pre-procedure imaging will be completed to evaluate proper sizing.

Potential risks associated with the procedure include:

  • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding.
  • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pacemaker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis(narrowing), too much fluid around the heart, injury to the structure of the heart.
  • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise.
  • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin.
  • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling.

Additional potential risks specifically associated with the use of the heart valve include:

  • Valve movement after deployment, blockage or disruption of blood flow through the heart, need for additional heart surgery and possible removal of the SAPIEN 3 valve, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue in growth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories.

CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician.

Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN, Edwards SAPIEN 3, SAPIEN, and SAPIEN 3 are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

© 2017 Edwards Lifesciences Corporation. All rights reserved. PP--US-2507 v1.0

Edwards Lifesciences One Edwards Way, Irvine CA 92614 USA edwards.com

4500 San Pablo Rd S

Jacksonville, FL 32224

Contact Information

(904) 956-3212

Dr. Richard Agnew, MD

Dr. Richard Agnew, MD

Accepted insurance

  • Assurant Health
  • Blue Cross Blue Shield
  • Cigna
  • Humana
  • Medicaid
  • UnitedHealthCare
  • WellCare

*Please verify this information when scheduling an appointment.

Background Check

No malpractice claims found for Florida
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Agnew's experience treating your condition or procedure

Dr. Agnew's Top Procedures and Conditions

Treatment Frequency
Partial Lung Collapse
high
high

Treatment Frequency

Dr. Agnew treats Partial Lung Collapse more than 86% of his peers

Dr. Agnew treats this condition more than 86% of his peers

Lung Surgery
normal
normal

Treatment Frequency

Dr. Agnew performs Lung Surgery more than 74% of his peers

Dr. Agnew performs this procedure more than 74% of his peers

Vascular Disease
normal
normal

Treatment Frequency

Dr. Agnew treats Vascular Disease more than 70% of his peers

Dr. Agnew treats this condition more than 70% of his peers

Dr. Agnew's conditions and procedures:

Abdominal Disorders
Abdominal Pain
Abscess
Abscess or Cyst Drainage or Aspiration
Abscess or Fluid Incision and Drainage
Adrenal Gland Cancer
Anal Disorders
Aneurysm
Anorectal Abscess
Appendicitis
Benign Tumor
Biliary Atresia
Bone Marrow Biopsy
Breast Cancer
Breast Diseases
Cancer
Cerebrospinal Fluid Leak (CSF Leak)
Cholecystitis and Gallstones
Colectomy
Collapsed Lung (Pneumothorax)
Colon and Rectal Surgery
Constipation
Crohn's Disease
Decortication and Pleurectomy
Diaphragmatic and-or Hiatal Hernia
Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
Embolectomy, Thrombectomy, or Vessel Exploration
Empyema
Esophageal Cancer
Esophageal Diseases
Esophageal Fistula
Esophageal Surgery
Esophagomyotomy
Esophagomyotomy With Robotic Assistance
Excision of Skin Lesion
Excision of Tracheal Tumor or Stenosis
Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
Fracture
Gastroenterology Procedures
Gastrointestinal Diseases
Gastrotomy
Graft vs Host Disease
Gynecologic Cancer
Head and Neck Cancer
Head and Neck Surgery
Heart Surgery
Hemorrhoids
Hernia
Hyperparathyroidism
Incision and Removal of Foreign Object
Inflammatory Bowel Disease
Intestinal Obstruction
Kidney Surgery
Lipomas
Liver Cancer
Lobectomy, Open
Lung Cancer
Lung Removal (Partial or Complete): Open, or Resection of Lung Tumor: Open
Lung Removal, Open
Lung Surgery
Lymph Node Biopsy or Excision
Neuroendocrine Tumors
Open Thymectomy
Partial Lung Collapse
Peripheral Arterial Aneurysm
Peripheral Arterial Aneurysm and Dissection
Peripheral Arterial Dissection
Peripheral Arterial Embolism and Thrombosis
Peripheral Artery Bypass
Peripheral Artery Catheterization
Peripheral Vascular Disease (PAD, PVD)
Pleura Cancer
Pleural Effusion
Port Placements or Replacements
Pulmonary Disease
Pyloric Stenosis
Removal or Destruction of Rectal or Intestinal Tumor (incl. Colonoscopy, Proctosigmoidoscopy, Sigmoidoscopy and Control of Hemorrhage)
Renal Transplant and Nephrectomy
Rib Fracture
Ruptured Aortic Aneurysm
Secondary Malignancies
Segmentectomy, Open
Skin Grafts
Soft Tissue Sarcoma
Splenectomy
Splenectomy and Splenorrhaphy
Stomach Diseases
Stomach Surgery
Thoracentesis
Thoracoscopic Lobectomy
Thoracoscopic Segmentectomy
Thoracoscopic Wedge Resection
Thromboendarterectomy or Excision of Infected Graft
Thrombosis
Tracheal Surgery
Ulcer
Ulcerative Colitis
Umbilical Hernia
Varicose Veins
Vascular Disease
Vascular Surgical Procedure
Ventral Hernia
Video-Assisted Thoracoscopic Surgery (VATS) or Thoracotomy
Wound Repair

About Me

Biography

Dr. Richard Agnew, MD is a general surgery specialist in Jacksonville, FL and has been practicing for 43 years. He graduated from Vanderbilt University School Of Medicine in 1975 and specializes in general surgery.

Specialties

  • General Surgery

Education

  • Vanderbilt University
    Residency Hospital
  • Vanderbilt University
    Internship Hospital
  • 1975
    Vanderbilt University School Of Medicine
    Medical School
    1975

Languages

  • Spanish
  • English

Dr. Agnew's Reviews

Likelihood to recommend Dr. Agnew

3.4

Based on 5 reviews

5 Stars
60%
(3)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
40%
(2)

Leave a review

How likely are you to recommend
Dr. Agnew?
(Select your rating)
Average Wait Time
  • 10 – 15 minutes
Dr. Agnew's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Richard Agnew, MD
Reply
Dr Agnew performed heart surgery on me at St Luke's hospital on Belfort . When I awoke my left leg was paralyzed. They determined I suffered damage to the peroneal nerve in the leg most likely due to it being pressed against something on the gurney in the operating room. My leg remains paralyzed...Read More
Was this helpful?
thumbs up icon option
thumbs down icon option2
×Post a ResponseAre you Dr. Richard Agnew, MD?

Leave a review

How was your experience with Dr. Agnew?

Locations

Insurance accepted

Accepted insurance can change. Please double-check when making an appointment.

Assurant Health
Blue Cross Blue Shield
Blue Card PPO
Cigna
Cigna HMO
Cigna PPO
Great West Healthcare-Cigna PPO
Open Access
Humana
Medicaid
UnitedHealthCare
Choice Plus POS
Options PPO
United Healthcare
WellCare
WellCare PPO

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Agnew treats patients.

Learn more

Mayo Clinic

Jacksonville, FL

Compare General Surgeons

More providers who are similar to Dr. Agnew

Show All General Surgeons